NASDAQ:TRAW

Traws Pharma Stock Insider Trading

*Your capital is at risk

$2.08

-0.0900 (-4.15%)

At Close: Nov 17, 2025

Traws Pharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 913.9B and sold 12.2B TRAW shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	913.9B shares
● Sell	12.2B shares
94% Buy Activity Weak Negative Correlation
Sell Signal Low Confidence Nov 04, 2025 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 100. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Oct 12, 2025 Buy	Stock Option (right to purchase) A-Award	Savchuk Nikolay Chief Operating Officer	C-Suite Officer	22 435 Value: $67.5K
Oct 12, 2025 Buy	Stock Option (right to purchase) A-Award	Redfield Robert Chief Medical Officer	Officer	32 406 Value: $97.5K
Oct 12, 2025 Buy	Stock Option (right to purchase) A-Award	Pauza Charles David Chief Science Officer Virology	Officer	32 406 Value: $97.5K
Oct 12, 2025 Buy	Stock Option (right to purchase) A-Award	Dukes Iain D. Chief Executive Officer	CEO / President	64 839 Value: $195.2K
Oct 12, 2025 Buy	Stock Option (right to purchase) A-Award	Cautreels Werner Director	Director	11 530 Value: $34.7K
Oct 12, 2025 Buy	Stock Option (right to purchase) A-Award	Stover Jack E Director	Director	11 530 Value: $34.7K
Oct 12, 2025 Buy	Stock Option (right to purchase) A-Award	Clarke Trafford Director	Director	11 530 Value: $34.7K
Oct 12, 2025 Buy	Stock Option (right to purchase) A-Award	Shoemaker Mary Teresa Director	Director	11 530 Value: $34.7K
Oct 12, 2025 Buy	Stock Option (right to purchase) A-Award	Savchuk Nikolay Chief Operating Officer	C-Suite Officer	22 435 Value: $67.5K
Oct 12, 2025 Buy	Stock Option (right to purchase) A-Award	Redfield Robert Chief Medical Officer	Officer	32 406 Value: $97.5K
Oct 12, 2025 Buy	Stock Option (right to purchase) A-Award	Pauza Charles David Chief Science Officer Virology	Officer	32 406 Value: $97.5K
Oct 12, 2025 Buy	Stock Option (right to purchase) A-Award	Dukes Iain D. Chief Executive Officer	CEO / President	64 839 Value: $195.2K
Oct 12, 2025 Buy	Stock Option (right to purchase) A-Award	Cautreels Werner Director	Director	11 530 Value: $34.7K
Oct 12, 2025 Buy	Stock Option (right to purchase) A-Award	Stover Jack E Director	Director	11 530 Value: $34.7K
Oct 12, 2025 Buy	Stock Option (right to purchase) A-Award	Clarke Trafford Director	Director	11 530 Value: $34.7K
Oct 12, 2025 Buy	Stock Option (right to purchase) A-Award	Shoemaker Mary Teresa Director	Director	11 530 Value: $34.7K
Oct 01, 2025 Buy	Stock Option (right to purchase) A-Award	Leaman John Harold Director	Director	15 609 Value: $29.5K
Oct 01, 2025 Buy	Common Stock J-Other	Leaman John Harold Insider	Other	0 Value: $0
Oct 01, 2025 Buy	Stock Option (right to purchase) A-Award	Leaman John Harold Director	Director	15 609 Value: $29.5K
Oct 01, 2025 Buy	Common Stock J-Other	Leaman John Harold Insider	Other	0 Value: $0
Jun 19, 2025 Buy	Stock Option (right to purchase) A-Award	Clarke Trafford Director	Director	23 000 Value: $38.0K
Jun 19, 2025 Buy	Stock Option (right to purchase) A-Award	Stover Jack E Director	Director	23 000 Value: $38.0K
Jun 19, 2025 Buy	Stock Option (right to purchase) A-Award	Shoemaker Mary Teresa Director	Director	23 000 Value: $38.0K
Jun 19, 2025 Buy	Stock Option (right to purchase) A-Award	Cautreels Werner Director	Director	23 000 Value: $38.0K
Jun 19, 2025 Buy	Stock Option (right to purchase) A-Award	Clarke Trafford Director	Director	23 000 Value: $38.0K

About Insider Power

Insider Power is a proprietary algorithm developed by Stockinvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks